Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.38NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.43.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.43.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.46NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.48NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.47.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.47.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.7.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.8.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HV.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.8NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.8.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.8.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.39NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JD.1.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HK.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.9NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.43NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.21NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JC.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.5.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XDPNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDPNSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used